FDA Guidance Practices Are Good Model For HHS – General Counsel Azar
This article was originally published in The Gray Sheet
Executive Summary
FDA is a good role model for HHS agencies to follow in creating good guidance practices, HHS General Counsel Alex Azar told the Food & Drug Law Institute "lawyer's lunch" April 17
You may also be interested in...
FDA Opens Floor For Debate Of Off-Label Claims, First Amendment Issues
FDA's request for comments on First Amendment issues creates a forum for stakeholders to submit comments on FDA's policy regarding off-label claims
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.